GSK Planned Off-Label Pitch At Every OB-GYN, Families Say

By Alison Noon · June 27, 2018, 10:15 PM EDT

"Bombshell" depositions have allegedly revealed GlaxoSmithKline employed — but later fired — a small team of specialists to secure hedge fund money and deploy pharmaceutical sales representatives to ask every OB-GYN...

To view the full article, register now.

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number

1:15-md-02657

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 13, 2015